TY  - BOOK
AU  - Badr, Salem
AU  - Fatemi, Omid
AU  - Kitabata, Hironori
AU  - Minha, Sa'ar
AU  - Pichard, Augusto D
AU  - Satler, Lowell F
AU  - Suddath, William O
AU  - Torguson, Rebecca
AU  - Waksman, Ron
TI  - Safety and long-term outcomes after percutaneous coronary intervention in patients with human immunodeficiency virus. []
SN  - 1522-1946
PY  - 2015///
KW  - *Coronary Artery Disease/th [Therapy]
KW  - *HIV Infections/co [Complications]
KW  - *Percutaneous Coronary Intervention
KW  - Aged
KW  - Chi-Square Distribution
KW  - Coronary Artery Disease/co [Complications]
KW  - Coronary Artery Disease/di [Diagnosis]
KW  - Coronary Artery Disease/mo [Mortality]
KW  - Databases, Factual
KW  - Drug-Eluting Stents
KW  - Female
KW  - HIV Infections/di [Diagnosis]
KW  - HIV Infections/mo [Mortality]
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Myocardial Infarction/et [Etiology]
KW  - Odds Ratio
KW  - Patient Selection
KW  - Percutaneous Coronary Intervention/ae [Adverse Effects]
KW  - Percutaneous Coronary Intervention/is [Instrumentation]
KW  - Percutaneous Coronary Intervention/mo [Mortality]
KW  - Proportional Hazards Models
KW  - Retrospective Studies
KW  - Risk Assessment
KW  - Risk Factors
KW  - Time Factors
KW  - Treatment Outcome
KW  - MedStar Heart & Vascular Institute
KW  - Journal Article
KW  - Observational Study
N1  - Available online from MWHC library: 1996 - present, Available in print through MWHC library: 1996 - 2006
N2  - BACKGROUND: Sparse data exists regarding the risk of patients with HIV who undergo PCI; CONCLUSION: PCI in HIV+ patients is safe, with high procedural success rates, and produces similar outcomes to those seen in HIV- patients at 2 years. HIV+ patients should be treated with DES if possible.Copyright � 2014 Wiley Periodicals, Inc; METHODS: Using a case-control design, we compared baseline characteristics, procedure-related outcomes, in-hospital, and 2-year clinical outcomes of 112 consecutive HIV+ patients versus 112 HIV- controls matched for age, gender, and diabetes mellitus who underwent PCI from April 2003 to September 2011; OBJECTIVE: This study aims to report the long-term outcomes after percutaneous coronary intervention (PCI) in human immunodeficiency virus (HIV+) patients; RESULTS: Baseline characteristics were generally comparable, save for more African Americans and history of chronic renal insufficiency in the HIV+ vs. HIV- group (62.5% vs. 21.4%, P < 0.001) and (27.7% vs. 9.9%, P < 0.001). There was no correlation between CD4 nadir count and extent and diffuseness of coronary artery disease. The occurrence of major adverse cardiac events at 2 years was similar in both groups. Multivariable analysis for independent correlates of major adverse cardiac events at 2 years detected patients with a history of chronic renal insufficiency (OR: 2.44, 95% confidence interval: 1.02-5.83; P = 0.04) and acute myocardial infarction (OR: 2.92, 95% confidence interval: 1.39-6.15; P = 0.005) as correlates for outcome. Post-hoc analysis showed that drug-eluting stent (DES) use in the HIV+ group was beneficial
UR  - http://dx.doi.org/10.1002/ccd.25466
ER  -